International scientists have found autism's cause

Five clear, replicable, and related discoveries explaining how autism is triggered have formed an undeniably clear picture of autism’s causation, and possibly ways to alleviate the symptoms, too. Most of the research that has created this understanding has been published in the last 36 months, and largely from international scientists in the United Kingdom, Canada, France, Israel, and China. 

In early December 2017, the team published a paper that for the first time looked at the brain tissue of subjects with autism to determine the level of aluminum (note: they spell “aluminum” as “aluminium” in the United Kingdom) found within their brain tissue. For anyone trying to convince the world that “the science is settled and vaccines don’t cause autism,” the study’s findings are deeply contradictory to that statement. In a post written by the Professor on the day his study was published, he explained the groundbreaking results:

“…while the aluminium content of each of the 5 brains [of people with autism] was shockingly high it was the location of the aluminium in the brain tissue which served as the standout observation…The new evidence strongly suggests that aluminium is entering the brain in ASD [autism spectrum disorders] via pro-inflammatory cells which have become loaded up with aluminium in the blood and/or lymph, much as has been demonstrated for monocytes at injection sites for vaccines including aluminium adjuvants.”

Dr.’s quote includes a reference to “monocytes at injection sites” and the fact that the interaction between these monocytes and aluminum has been demonstrated in previous published science. I know, that sounds pretty technical, but bear with me. A “monocyte” is a type of white blood cell, of which one form of monocyte is a “macrophage.” A macrophage can be thought of as the garbage man of the immune system, eating up foreign substances, cell debris, etc. As you will see in a moment, macrophages appear to be playing a critical and devastating role in triggering autism, serving to escort aluminum injected from a vaccine directly into the brain, where it can disrupt brain development and trigger autism.

Dr.’s study — “Aluminium in brain tissue and autism” — is the final piece of a puzzle that first started to come together in 2004, and picked up steam since 2010, that has dramatically furthered the scientific understanding of exactly how a vaccine can trigger autism. This timeline is critical to recognize, because the Vaccine Court in the United States dismissed the vaccine-autism hypothesis in 2009, long before most of what I’m about to explain even existed. Science is a continuum, an emergence of truth through many different studies that often have to be pieced together before the picture becomes clear. And, scientific progress can sometimes move slowly until that moment when an emerging truth presents itself in such a way that it can no longer be denied. In my opinion, Dr.’s study provided the only data missing from an airtight explanation of what happened to my son and so many other children.

Why is aluminum in vaccines at all?
Aluminum is a critical component of most vaccines given to children. It serves as an “adjuvant” meaning the aluminum serves to “wake up” the immune system, provoking the immune system to recognize the “antigen” within the vaccine for whatever disease the vaccine serves to protect against. The amount of aluminum in vaccines given to children skyrocketed beginning in the early 1990s for two reasons: 1), more vaccines were added to the children’s vaccine schedule and, 2), the vaccination rate for all vaccines given to children rose (from 50–60% of children vaccinated in the mid-1980s to over 90% today). A child in the mid-1980s would have received 1,250 micrograms of aluminum from their vaccines by their 18-month birthday if they were fully vaccinated. Today, that number is 4,925 micrograms, a near-quadrupling of total aluminum. 


 Mystifyingly, aluminum has never experienced biological testing to consider its safety for being injected into babies, having been “grandfathered” into our modern safety standards. Canadian scientists addressed this omission in a critical study they published in 2011 titled, “Aluminum Vaccine Adjuvants: Are they Safe?” They wrote:

“Aluminum is an experimentally demonstrated neurotoxin and the most commonly used vaccine adjuvant. Despite almost 90 years of widespread use of aluminum adjuvants, medical science’s understanding about their mechanisms of action is still remarkably poor. There is also a concerning scarcity of data on toxicology and pharmacokinetics of these compounds. In spite of this, the notion that aluminum in vaccines is safe appears to be widely accepted. Experimental research, however, clearly shows that aluminum adjuvants have a potential to induce serious immunological disorders in humans. In particular, aluminum in adjuvant form carries a risk for autoimmunity, long-term brain inflammation and associated neurological complications and may thus have profound and widespread adverse health consequences.”

THIS IS ONLY FOR INFORMATION, ALWAYS CONSULT YOU PHYSICIAN BEFORE HAVING ANY PARTICULAR FOOD/ MEDICATION/EXERCISE/OTHER REMEDIES.                                                                                                                                                                                                      PS- THOSE INTERESTED IN RECIPES ARE FREE TO VIEW MY BLOG-                                                                                           https://gseasyrecipes.blogspot.com/   
FOR INFO ABOUT KNEE REPLACEMENT, YOU CAN VIEW MY BLOG-                                                           https:// kneereplacement-stickclub.blogspot.com/                              
FOR CROCHET DESIGNS                                                                                                                                                                                                                                         https://my crochet creations.blogspot.com/ 

Risk of breast cancer returning lasts for years

Many women who follow initial breast cancer treatment with five years of hormone therapy to keep tumors at bay may still experience new malignancies up to two decades after their diagnosis, a study suggests.

Researchers examined data from 88 clinical trials involving 62,923 women with estrogen receptor (ER)-positive tumors. After treating ER-positive tumors with chemotherapy, radiation or surgery, women typically get five years of follow-up therapy with daily hormone-based pills – either tamoxifen or aromatase inhibitors. The goal of the adjuvant therapy is to destroy any lingering cancer cells not killed by initial treatment.

All of the women were cancer-free when they completed five years of adjuvant hormone-based therapy.

During the next 15 years, however, cancer returned for 41% of the highest-risk women in the study who originally had the largest tumors that had spread the most beyond the breast, the study found.

Even the lowest-risk women who originally had small tumors that hadn’t spread to the lymph nodes or other parts of the body still had 10% odds of cancer coming back during the study, researchers report.

“We know that adjuvant (hormone-based) therapy for 5 years substantially reduces the risk of recurrence and mortality,” said senior study author.

“We now have good evidence that extending adjuvant (hormone-based) therapy beyond five years continues to suppress and reduce recurrence and mortality,” author said.

Doctors have long known that five years of tamoxifen reduces recurrence by approximately half during treatment, and by nearly a third over the next five years. Aromatase inhibitors, which work only in post-menopausal women, are even more effective than tamoxifen at reducing recurrence and death from breast cancer.

Some recent research suggests an additional five years of hormone-based therapy is even more effective, but the side effects make some women reluctant to continue. Life-threatening side effects are rare, but women taking these hormones can have menopause symptoms like hot flashes and vaginal dryness.

The data suggest that women with ER-positive breast cancer should at least consider continuing adjuvant therapy beyond five years, the authors conclude.

“Breast cancer cells can travel from the primary tumor to the lymph nodes and can circulate throughout the body undetectable with current screening (methods) and over time, these circulating cancer cells can attach to other organs in the body and this is generally when there is a detectable cancer recurrence,” said a cancer researcher.

“One way that adjuvant breast cancer treatment works is to kill and/or stop the undetectable cancer cells from growing and dividing,” a researcher said.

Even though the study suggests some women may have more risk of recurrence based on their original tumor characteristics, it can still be hard to predict and women need to remain vigilant, said the Dr.

“Breast cancer can be dormant for many years, so that women can have no apparent disease, but can still recur years later if the tumor becomes active again,” said another researcher. “We do not know why some cancers become active again after years of dormancy.”

Women need regular checkups and breast screenings, as well as annual mammograms, said a Dr.

“If a woman is high risk for breast cancer, such as a lady with a gene mutation, she may need both mammograms and breast MRIs,” a Dr. added.

“Additionally, women should maintain a healthy weight, exercise, stop smoking, and limit alcohol consumption to reduce their risk of recurrence.”

THIS IS ONLY FOR INFORMATION, ALWAYS CONSULT YOU PHYSICIAN BEFORE HAVING ANY PARTICULAR FOOD/ MEDICATION/EXERCISE/OTHER REMEDIES.   

PS- THOSE INTERESTED IN RECIPES ARE FREE TO VIEW MY BLOG-                      

HTTP:GSEASYRECIPES.BLOGSPOT.COM/
FOR INFO ABOUT KNEE REPLACEMENT, YOU CAN VIEW MY BLOG-                                                                       

HTTP://KNEE REPLACEMENT-STICK CLUB.BLOGSPOT.COM/
FOR CROCHET DESIGNS
HTTP://MY CROCHET CREATIONS.BLOGSPOT.COM